Literature DB >> 17764190

Stereoselective synthesis of tetrahydrofuran lignans via BF(3) x OEt(2)-promoted reductive deoxygenation/epimerization of cyclic hemiketal: synthesis of (-)-odoratisol C, (-)-futokadsurin A, (-)-veraguensin, (+)-fragransin A(2), (+)-galbelgin, and (+)-talaumidin.

Hyoungsu Kim1, Ceshea M Wooten, Yongho Park, Jiyong Hong.   

Abstract

A versatile route to the synthesis of 2,5-diaryl-3,4-dimethyltetrahydrofuran lignans, (-)-odoratisol C (1), (-)-futokadsurin A (2), (-)-veraguensin (3), (+)-fragransin A2 (4), (+)-galbelgin (5), and (+)-talaumidin (6), is described. Central to the synthesis of the lignans is BF(3) x OEt(2)-promoted deoxygenation/epimerization of the hemiketal 9a followed by stereoselective reduction of the oxocarbenium ion intermediates 8a,b.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764190     DOI: 10.1021/ol7016388

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

Review 1.  Neurotrophic natural products: chemistry and biology.

Authors:  Jing Xu; Michelle H Lacoske; Emmanuel A Theodorakis
Journal:  Angew Chem Int Ed Engl       Date:  2013-12-18       Impact factor: 15.336

2.  Analysis of HIF-1 inhibition by manassantin A and analogues with modified tetrahydrofuran configurations.

Authors:  Amanda C Kasper; Eui Jung Moon; Xiangqian Hu; Yongho Park; Ceshea M Wooten; Hyoungsu Kim; Weitao Yang; Mark W Dewhirst; Jiyong Hong
Journal:  Bioorg Med Chem Lett       Date:  2009-04-22       Impact factor: 2.823

3.  Enantio- and diastereoselective intermolecular Stetter reaction of glyoxamide and alkylidene ketoamides.

Authors:  Qin Liu; Tomislav Rovis
Journal:  Org Lett       Date:  2009-07-02       Impact factor: 6.005

4.  Nucleophilic addition of organozinc reagents to 2-sulfonyl cyclic ethers: stereoselective synthesis of manassantins A and B.

Authors:  Hyoungsu Kim; Amanda C Kasper; Eui Jung Moon; Yongho Park; Ceshea M Wooten; Mark W Dewhirst; Jiyong Hong
Journal:  Org Lett       Date:  2009-01-01       Impact factor: 6.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.